CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765)
China flag China · Delayed Price · Currency is CNY
22.41
-0.42 (-1.84%)
Sep 9, 2024, 1:54 PM CST

CSPC Innovation Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
1,4823,4222,1961,2441,139475.14
Upgrade
Trading Asset Securities
---413.59321.94960.09
Upgrade
Cash & Short-Term Investments
1,4823,4222,1961,6581,4611,435
Upgrade
Cash Growth
-48.90%55.86%32.43%13.51%1.77%817.71%
Upgrade
Accounts Receivable
556.63545.03716.75508.94303.96349.77
Upgrade
Other Receivables
2.51.421.561.371.81.47
Upgrade
Receivables
559.13546.45718.31510.31305.76351.24
Upgrade
Inventory
300.9223.68238.13262111124.23
Upgrade
Other Current Assets
96.5827.5738.4756.9235.626.32
Upgrade
Total Current Assets
2,4384,2203,1912,4871,9131,937
Upgrade
Property, Plant & Equipment
2,4031,0591,055926.42727.49678.17
Upgrade
Long-Term Investments
263.28267.07253.49243.19235.87156.29
Upgrade
Goodwill
----3.473.47
Upgrade
Other Intangible Assets
228.448.0350.4252.8155.2157.57
Upgrade
Long-Term Deferred Tax Assets
1717.3618.8812.510.3912.88
Upgrade
Other Long-Term Assets
535.5120.6115.919.069.436.99
Upgrade
Total Assets
5,8865,6324,5843,7412,9552,852
Upgrade
Accounts Payable
311.07173.68178.75129.1764.1692.7
Upgrade
Accrued Expenses
46.763.4266.2454.5725.118.63
Upgrade
Current Portion of Long-Term Debt
--0.22---
Upgrade
Current Portion of Leases
0.820.81-0.84--
Upgrade
Current Income Taxes Payable
13.9628.3634.7714.9510.2614
Upgrade
Current Unearned Revenue
20.9419.868.2630.3725.27-
Upgrade
Other Current Liabilities
483.36224.77234.52178.75109.46275.42
Upgrade
Total Current Liabilities
876.86510.84582.77408.64234.24400.76
Upgrade
Long-Term Debt
--19.8---
Upgrade
Long-Term Leases
0.430.84----
Upgrade
Long-Term Unearned Revenue
91.0433.2637.2134.2733.3135.66
Upgrade
Long-Term Deferred Tax Liabilities
0.030.020.060.670.450.65
Upgrade
Total Liabilities
968.34544.96639.84443.58268437.06
Upgrade
Common Stock
1,4051,171618.93546420200
Upgrade
Additional Paid-In Capital
975.51,0751,1381,211882.281,102
Upgrade
Retained Earnings
1,7512,8352,1771,5331,3761,104
Upgrade
Treasury Stock
-226.99-4.25----
Upgrade
Comprensive Income & Other
1.61.980.72-1.2-0.10.03
Upgrade
Total Common Equity
3,9055,0793,9363,2892,6782,406
Upgrade
Minority Interest
1,0128.358.598.268.798.91
Upgrade
Shareholders' Equity
4,9175,0873,9443,2982,6872,415
Upgrade
Total Liabilities & Equity
5,8865,6324,5843,7412,9552,852
Upgrade
Total Debt
1.251.6520.020.84--
Upgrade
Net Cash (Debt)
1,4813,4212,1761,6571,4611,435
Upgrade
Net Cash Growth
-48.55%57.22%31.29%13.45%1.77%1572.70%
Upgrade
Net Cash Per Share
1.082.461.631.241.241.30
Upgrade
Filing Date Shares Outstanding
1,3971,4051,3371,1791,1791,179
Upgrade
Total Common Shares Outstanding
1,3971,4051,3371,1791,1791,179
Upgrade
Working Capital
1,5623,7092,6082,0791,6791,536
Upgrade
Book Value Per Share
2.803.622.942.792.272.04
Upgrade
Tangible Book Value
3,6775,0313,8853,2372,6192,345
Upgrade
Tangible Book Value Per Share
2.633.582.912.742.221.99
Upgrade
Buildings
1,019615.21609.24430.75397.71382.16
Upgrade
Machinery
1,8371,009925.79701.65475.66447.03
Upgrade
Construction In Progress
355.662.1570.74294.97154.83108.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.